ID B4GT6_HUMAN Reviewed; 382 AA. AC Q9UBX8; O60514; Q6NT09; DT 21-FEB-2001, integrated into UniProtKB/Swiss-Prot. DT 01-MAY-2000, sequence version 1. DT 24-JAN-2024, entry version 182. DE RecName: Full=Beta-1,4-galactosyltransferase 6 {ECO:0000305}; DE Short=Beta-1,4-GalTase 6; DE Short=Beta4Gal-T6; DE Short=b4Gal-T6; DE EC=2.4.1.-; DE AltName: Full=Glucosylceramide beta-1,4-galactosyltransferase; DE EC=2.4.1.274 {ECO:0000269|PubMed:1551920, ECO:0000269|PubMed:3099851}; DE AltName: Full=Lactosylceramide synthase {ECO:0000303|PubMed:24498430}; DE Short=LacCer synthase {ECO:0000303|PubMed:24498430}; DE AltName: Full=UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 6; DE AltName: Full=UDP-Gal:glucosylceramide beta-1,4-galactosyltransferase {ECO:0000303|PubMed:3099851}; DE AltName: Full=UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 6; GN Name=B4GALT6 {ECO:0000312|HGNC:HGNC:929}; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RX PubMed=9597550; DOI=10.1093/glycob/8.5.517; RA Lo N.-W., Shaper J.H., Pevsner J., Shaper N.L.; RT "The expanding beta 4-galactosyltransferase gene family: messages from the RT databanks."; RL Glycobiology 8:517-526(1998). RN [2] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RC TISSUE=Brain; RX PubMed=10320813; DOI=10.1016/s1388-1981(99)00051-7; RA Takizawa M., Nomura T., Wakisaka E., Yoshizuka N., Aoki J., Arai H., RA Inoue K., Hattori M., Matsuo N.; RT "cDNA cloning and expression of human lactosylceramide synthase."; RL Biochim. Biophys. Acta 1438:301-304(1999). RN [3] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1). RA Sato T.; RT "Human beta-1,4-galactosyltransferase VI."; RL Submitted (MAR-1999) to the EMBL/GenBank/DDBJ databases. RN [4] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RX PubMed=16177791; DOI=10.1038/nature03983; RA Nusbaum C., Zody M.C., Borowsky M.L., Kamal M., Kodira C.D., Taylor T.D., RA Whittaker C.A., Chang J.L., Cuomo C.A., Dewar K., FitzGerald M.G., Yang X., RA Abouelleil A., Allen N.R., Anderson S., Bloom T., Bugalter B., Butler J., RA Cook A., DeCaprio D., Engels R., Garber M., Gnirke A., Hafez N., Hall J.L., RA Norman C.H., Itoh T., Jaffe D.B., Kuroki Y., Lehoczky J., Lui A., RA Macdonald P., Mauceli E., Mikkelsen T.S., Naylor J.W., Nicol R., Nguyen C., RA Noguchi H., O'Leary S.B., Piqani B., Smith C.L., Talamas J.A., Topham K., RA Totoki Y., Toyoda A., Wain H.M., Young S.K., Zeng Q., Zimmer A.R., RA Fujiyama A., Hattori M., Birren B.W., Sakaki Y., Lander E.S.; RT "DNA sequence and analysis of human chromosome 18."; RL Nature 437:551-555(2005). RN [5] RP NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. RA Mural R.J., Istrail S., Sutton G., Florea L., Halpern A.L., Mobarry C.M., RA Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., RA Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., RA Turner R., Yooseph S., Lu F., Nusskern D.R., Shue B.C., Zheng X.H., RA Zhong F., Delcher A.L., Huson D.H., Kravitz S.A., Mouchard L., Reinert K., RA Remington K.A., Clark A.G., Waterman M.S., Eichler E.E., Adams M.D., RA Hunkapiller M.W., Myers E.W., Venter J.C.; RL Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases. RN [6] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). RC TISSUE=Lung; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [7] RP FUNCTION AS GLUCOSYLCERAMIDE BETA-1,4-GALACTOSYLTRANSFERASE, CATALYTIC RP ACTIVITY, COFACTOR, AND BIOPHYSICOCHEMICAL PROPERTIES. RX PubMed=3099851; DOI=10.1016/0304-4165(87)90136-x; RA Chatterjee S., Castiglione E.; RT "UDPgalactose:glucosylceramide beta 1->4-galactosyltransferase activity in RT human proximal tubular cells from normal and familial hypercholesterolemic RT homozygotes."; RL Biochim. Biophys. Acta 923:136-142(1987). RN [8] RP FUNCTION AS GLUCOSYLCERAMIDE BETA-1,4-GALACTOSYLTRANSFERASE, AND CATALYTIC RP ACTIVITY. RX PubMed=1551920; DOI=10.1016/s0021-9258(19)50550-6; RA Chatterjee S., Ghosh N., Khurana S.; RT "Purification of uridine diphosphate-galactose:glucosyl ceramide, beta 1-4 RT galactosyltransferase from human kidney."; RL J. Biol. Chem. 267:7148-7153(1992). RN [9] RP REVIEW. RX PubMed=10580128; DOI=10.1016/s0304-4165(99)00168-3; RA Amado M., Almeida R., Schwientek T., Clausen H.; RT "Identification and characterization of large galactosyltransferase gene RT families: galactosyltransferases for all functions."; RL Biochim. Biophys. Acta 1473:35-53(1999). RN [10] RP FUNCTION AS GLUCOSYLCERAMIDE BETA-1,4-GALACTOSYLTRANSFERASE. RX PubMed=24498430; DOI=10.1371/journal.pone.0088124; RA Yamaji T., Hanada K.; RT "Establishment of HeLa cell mutants deficient in sphingolipid-related genes RT using TALENs."; RL PLoS ONE 9:E88124-E88124(2014). CC -!- FUNCTION: Catalyzes the synthesis of lactosylceramide (LacCer) via the CC transfer of galactose from UDP-galactose to glucosylceramide (GlcCer) CC (PubMed:3099851, PubMed:1551920, PubMed:24498430). LacCer is the CC starting point in the biosynthesis of all gangliosides (membrane-bound CC glycosphingolipids) which play pivotal roles in the CNS including CC neuronal maturation and axonal and myelin formation (By similarity). CC {ECO:0000250|UniProtKB:Q9WVK5, ECO:0000269|PubMed:1551920, CC ECO:0000269|PubMed:24498430, ECO:0000269|PubMed:3099851}. CC -!- CATALYTIC ACTIVITY: CC Reaction=a beta-D-glucosyl-(1<->1')-N-acylsphing-4-enine + UDP-alpha-D- CC galactose = a beta-D-Gal-(1->4)-beta-D-Glc-(1<->1)-Cer(d18:1(4E)) + CC H(+) + UDP; Xref=Rhea:RHEA:31495, ChEBI:CHEBI:15378, CC ChEBI:CHEBI:17950, ChEBI:CHEBI:22801, ChEBI:CHEBI:58223, CC ChEBI:CHEBI:66914; EC=2.4.1.274; CC Evidence={ECO:0000269|PubMed:1551920, ECO:0000269|PubMed:24498430, CC ECO:0000269|PubMed:3099851}; CC PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:31496; CC Evidence={ECO:0000305|PubMed:3099851}; CC -!- COFACTOR: CC Name=Mn(2+); Xref=ChEBI:CHEBI:29035; CC Evidence={ECO:0000269|PubMed:3099851}; CC Name=Mg(2+); Xref=ChEBI:CHEBI:18420; CC Evidence={ECO:0000269|PubMed:3099851}; CC -!- ACTIVITY REGULATION: Inhibited by EDTA. {ECO:0000250|UniProtKB:O88419}. CC -!- BIOPHYSICOCHEMICAL PROPERTIES: CC Kinetic parameters: CC KM=3 uM for glucosylceramide {ECO:0000269|PubMed:3099851}; CC KM=0.5 uM for UDP-galactose {ECO:0000269|PubMed:3099851}; CC Vmax=0.06 nmol/h/mg enzyme toward glucosylceramide CC {ECO:0000269|PubMed:3099851}; CC Vmax=86 nmol/h/mg enzyme toward UDP-galactose CC {ECO:0000269|PubMed:3099851}; CC -!- PATHWAY: Protein modification; protein glycosylation. CC -!- PATHWAY: Sphingolipid metabolism. CC -!- SUBCELLULAR LOCATION: Golgi apparatus, Golgi stack membrane CC {ECO:0000250|UniProtKB:P15291}; Single-pass type II membrane protein. CC Note=Trans cisternae of Golgi stack. {ECO:0000250|UniProtKB:P15291}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q9UBX8-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9UBX8-2; Sequence=VSP_056554; CC -!- TISSUE SPECIFICITY: High expression in brain and adrenal gland, lower CC in liver, lung, colon and peripheral white blood cells. CC -!- SIMILARITY: Belongs to the glycosyltransferase 7 family. {ECO:0000305}. CC -!- WEB RESOURCE: Name=Functional Glycomics Gateway - GTase; CC Note=Beta-1,4-galactosyltransferase 6; CC URL="http://www.functionalglycomics.org/glycomics/molecule/jsp/glycoEnzyme/viewGlycoEnzyme.jsp?gbpId=gt_hum_441"; CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF038664; AAC39737.1; -; mRNA. DR EMBL; AF097159; AAD41695.1; -; mRNA. DR EMBL; AB024742; BAA76273.2; -; mRNA. DR EMBL; AC017100; -; NOT_ANNOTATED_CDS; Genomic_DNA. DR EMBL; CH471088; EAX01269.1; -; Genomic_DNA. DR EMBL; BC069620; AAH69620.1; -; mRNA. DR EMBL; BC074835; AAH74835.1; -; mRNA. DR EMBL; BC074884; AAH74884.1; -; mRNA. DR CCDS; CCDS11900.1; -. [Q9UBX8-1] DR RefSeq; NP_001317499.1; NM_001330570.1. DR RefSeq; NP_004766.2; NM_004775.3. [Q9UBX8-1] DR AlphaFoldDB; Q9UBX8; -. DR SMR; Q9UBX8; -. DR BioGRID; 114740; 25. DR IntAct; Q9UBX8; 4. DR STRING; 9606.ENSP00000306459; -. DR SwissLipids; SLP:000001379; -. [Q9UBX8-1] DR CAZy; GT7; Glycosyltransferase Family 7. DR GlyCosmos; Q9UBX8; 8 sites, No reported glycans. DR GlyGen; Q9UBX8; 8 sites. DR iPTMnet; Q9UBX8; -. DR PhosphoSitePlus; Q9UBX8; -. DR BioMuta; B4GALT6; -. DR DMDM; 13123991; -. DR MassIVE; Q9UBX8; -. DR MaxQB; Q9UBX8; -. DR PaxDb; 9606-ENSP00000306459; -. DR PeptideAtlas; Q9UBX8; -. DR ProteomicsDB; 66651; -. DR ProteomicsDB; 84097; -. [Q9UBX8-1] DR Antibodypedia; 41869; 144 antibodies from 27 providers. DR DNASU; 9331; -. DR Ensembl; ENST00000306851.10; ENSP00000306459.5; ENSG00000118276.12. [Q9UBX8-1] DR Ensembl; ENST00000383131.3; ENSP00000372613.3; ENSG00000118276.12. [Q9UBX8-2] DR GeneID; 9331; -. DR KEGG; hsa:9331; -. DR MANE-Select; ENST00000306851.10; ENSP00000306459.5; NM_004775.5; NP_004766.2. DR UCSC; uc002kwz.5; human. [Q9UBX8-1] DR AGR; HGNC:929; -. DR CTD; 9331; -. DR DisGeNET; 9331; -. DR GeneCards; B4GALT6; -. DR HGNC; HGNC:929; B4GALT6. DR HPA; ENSG00000118276; Tissue enhanced (retina). DR MIM; 604017; gene. DR neXtProt; NX_Q9UBX8; -. DR OpenTargets; ENSG00000118276; -. DR PharmGKB; PA25228; -. DR VEuPathDB; HostDB:ENSG00000118276; -. DR eggNOG; KOG3916; Eukaryota. DR GeneTree; ENSGT00940000158138; -. DR InParanoid; Q9UBX8; -. DR OMA; VVWDCII; -. DR OrthoDB; 306273at2759; -. DR PhylomeDB; Q9UBX8; -. DR TreeFam; TF312834; -. DR BioCyc; MetaCyc:ENSG00000118276-MONOMER; -. DR BRENDA; 2.4.1.274; 2681. DR PathwayCommons; Q9UBX8; -. DR Reactome; R-HSA-2022854; Keratan sulfate biosynthesis. DR Reactome; R-HSA-913709; O-linked glycosylation of mucins. DR Reactome; R-HSA-975577; N-Glycan antennae elongation. DR SignaLink; Q9UBX8; -. DR UniPathway; UPA00378; -. DR BioGRID-ORCS; 9331; 14 hits in 1144 CRISPR screens. DR ChiTaRS; B4GALT6; human. DR GenomeRNAi; 9331; -. DR Pharos; Q9UBX8; Tbio. DR PRO; PR:Q9UBX8; -. DR Proteomes; UP000005640; Chromosome 18. DR RNAct; Q9UBX8; Protein. DR Bgee; ENSG00000118276; Expressed in lateral nuclear group of thalamus and 184 other cell types or tissues. DR ExpressionAtlas; Q9UBX8; baseline and differential. DR GO; GO:0005794; C:Golgi apparatus; IBA:GO_Central. DR GO; GO:0032580; C:Golgi cisterna membrane; IEA:UniProtKB-SubCell. DR GO; GO:0000139; C:Golgi membrane; TAS:Reactome. DR GO; GO:0008378; F:galactosyltransferase activity; IDA:BHF-UCL. DR GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW. DR GO; GO:0008489; F:UDP-galactose:glucosylceramide beta-1,4-galactosyltransferase activity; IMP:UniProtKB. DR GO; GO:0005975; P:carbohydrate metabolic process; IEA:InterPro. DR GO; GO:0022010; P:central nervous system myelination; ISS:UniProtKB. DR GO; GO:0021955; P:central nervous system neuron axonogenesis; ISS:UniProtKB. DR GO; GO:0010706; P:ganglioside biosynthetic process via lactosylceramide; ISS:UniProtKB. DR GO; GO:0006688; P:glycosphingolipid biosynthetic process; IBA:GO_Central. DR GO; GO:0070085; P:glycosylation; IBA:GO_Central. DR GO; GO:0001572; P:lactosylceramide biosynthetic process; IDA:BHF-UCL. DR GO; GO:0042551; P:neuron maturation; ISS:UniProtKB. DR GO; GO:0006486; P:protein glycosylation; IEA:UniProtKB-UniPathway. DR CDD; cd00899; b4GalT; 1. DR InterPro; IPR003859; Galactosyl_T. DR InterPro; IPR027791; Galactosyl_T_C. DR InterPro; IPR027995; Galactosyl_T_N. DR InterPro; IPR029044; Nucleotide-diphossugar_trans. DR PANTHER; PTHR19300; BETA-1,4-GALACTOSYLTRANSFERASE; 1. DR PANTHER; PTHR19300:SF47; BETA-1,4-GALACTOSYLTRANSFERASE 6; 1. DR Pfam; PF02709; Glyco_transf_7C; 1. DR Pfam; PF13733; Glyco_transf_7N; 1. DR PRINTS; PR02050; B14GALTRFASE. DR SUPFAM; SSF53448; Nucleotide-diphospho-sugar transferases; 1. DR Genevisible; Q9UBX8; HS. PE 1: Evidence at protein level; KW Alternative splicing; Calcium; Disulfide bond; Glycoprotein; KW Glycosyltransferase; Golgi apparatus; Lipid biosynthesis; Lipid metabolism; KW Magnesium; Manganese; Membrane; Metal-binding; Reference proteome; KW Signal-anchor; Sphingolipid metabolism; Transferase; Transmembrane; KW Transmembrane helix. FT CHAIN 1..382 FT /note="Beta-1,4-galactosyltransferase 6" FT /id="PRO_0000080547" FT TOPO_DOM 1..14 FT /note="Cytoplasmic" FT /evidence="ECO:0000255" FT TRANSMEM 15..35 FT /note="Helical; Signal-anchor for type II membrane protein" FT /evidence="ECO:0000255" FT TOPO_DOM 36..382 FT /note="Lumenal" FT /evidence="ECO:0000255" FT BINDING 163..167 FT /ligand="UDP-alpha-D-galactose" FT /ligand_id="ChEBI:CHEBI:66914" FT /evidence="ECO:0000250|UniProtKB:Q9UBV7" FT BINDING 202..204 FT /ligand="UDP-alpha-D-galactose" FT /ligand_id="ChEBI:CHEBI:66914" FT /evidence="ECO:0000250|UniProtKB:Q9UBV7" FT BINDING 229..230 FT /ligand="UDP-alpha-D-galactose" FT /ligand_id="ChEBI:CHEBI:66914" FT /evidence="ECO:0000250|UniProtKB:Q9UBV7" FT BINDING 230 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /evidence="ECO:0000250|UniProtKB:Q9UBV7" FT BINDING 258 FT /ligand="UDP-alpha-D-galactose" FT /ligand_id="ChEBI:CHEBI:66914" FT /evidence="ECO:0000250|UniProtKB:Q9UBV7" FT BINDING 290 FT /ligand="UDP-alpha-D-galactose" FT /ligand_id="ChEBI:CHEBI:66914" FT /evidence="ECO:0000250|UniProtKB:Q9UBV7" FT BINDING 292..295 FT /ligand="N-acetyl-D-glucosamine" FT /ligand_id="ChEBI:CHEBI:506227" FT /evidence="ECO:0000250|UniProtKB:Q9UBV7" FT BINDING 323..324 FT /ligand="UDP-alpha-D-galactose" FT /ligand_id="ChEBI:CHEBI:66914" FT /evidence="ECO:0000250|UniProtKB:Q9UBV7" FT BINDING 323 FT /ligand="Mn(2+)" FT /ligand_id="ChEBI:CHEBI:29035" FT /evidence="ECO:0000250|UniProtKB:Q9UBV7" FT BINDING 334 FT /ligand="N-acetyl-D-glucosamine" FT /ligand_id="ChEBI:CHEBI:506227" FT /evidence="ECO:0000250|UniProtKB:Q9UBV7" FT CARBOHYD 71 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 75 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 83 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 84 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 99 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 122 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 307 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT CARBOHYD 367 FT /note="N-linked (GlcNAc...) asparagine" FT /evidence="ECO:0000255" FT DISULFID 108..152 FT /evidence="ECO:0000250|UniProtKB:P15291" FT DISULFID 223..242 FT /evidence="ECO:0000250|UniProtKB:P15291" FT VAR_SEQ 158..196 FT /note="Missing (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_056554" FT VARIANT 379 FT /note="I -> V (in dbSNP:rs34683195)" FT /id="VAR_054023" FT CONFLICT 194 FT /note="I -> V (in Ref. 1; AAC39737)" FT /evidence="ECO:0000305" SQ SEQUENCE 382 AA; 44914 MW; 18E39920744ED643 CRC64; MSVLRRMMRV SNRSLLAFIF FFSLSSSCLY FIYVAPGIAN TYLFMVQARG IMLRENVKTI GHMIRLYTNK NSTLNGTDYP EGNNSSDYLV QTTTYLPENF TYSPYLPCPE KLPYMRGFLN VNVSEVSFDE IHQLFSKDLD IEPGGHWRPK DCKPRWKVAV LIPFRNRHEH LPIFFLHLIP MLQKQRLEFA FYVIEQTGTQ PFNRAMLFNV GFKEAMKDSV WDCVIFHDVD HLPENDRNYY GCGEMPRHFA AKLDKYMYIL PYKEFFGGVS GLTVEQFRKI NGFPNAFWGW GGEDDDLWNR VHYAGYNVTR PEGDLGKYKS IPHHHRGEVQ FLGRYKLLRY SKERQYIDGL NNLIYRPKIL VDRLYTNISV NLMPELAPIE DY //